In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against Gram-positive bloodstream isolates
- 1 September 1992
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (7) , 641-644
- https://doi.org/10.1016/0732-8893(90)90043-u
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycinAntimicrobial Agents and Chemotherapy, 1991
- Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United StatesAntimicrobial Agents and Chemotherapy, 1991
- Emergence of Ciprofloxacin-Resistant Coagulase-Negative Staphylococcal Skin Flora in Immunocompromised Patients Receiving CiprofloxacinThe Journal of Infectious Diseases, 1990
- In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalisAntimicrobial Agents and Chemotherapy, 1989
- Activity of glycopeptides against vancomycin-resistant gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1989
- The enterococcus: High-level resistance to gentamicin and production of beta-lactamaseClinical Microbiology Newsletter, 1988
- Gram-positive infections in granulocytopenic patients: an important issue?Journal of Antimicrobial Chemotherapy, 1988
- Emergence of Vancomycin Resistance in Coagulase-Negative StaphylococciNew England Journal of Medicine, 1987